Linkster is a swiss-based precision medicine company focusing on multi-specific antibodies and tissue-specific delivery. The company creates next generation targeted therapeutics through its Flycode® platform for high-throughput cellular and in vivo antibody engineering.
Cooperation possibilities
Linkster has entered into several agreements with pharmaceutical and biotech companies and is actively seeking further partnerships for the co-development of innovative therapeutic products.
- http://www.linkstertx.com/
- iwan.zimmermann@linkstertherapeutics.com
- Iwan Zimmermann, PhD
